Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Osteoarthritis, Hip

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Osteoarthritis, Hip in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antoch, G; Bittersohl, B; Herten, M; Jäger, M; König, D; Krauspe, R; Kurzidem, S; Miese, F; Zilkens, C1

Trials

1 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Osteoarthritis, Hip

ArticleYear
Validity of gradient-echo three-dimensional delayed gadolinium-enhanced magnetic resonance imaging of hip joint cartilage: a histologically controlled study.
    European journal of radiology, 2013, Volume: 82, Issue:2

    Topics: Adult; Aged; Cartilage, Articular; Case-Control Studies; Contrast Media; Female; Heterocyclic Compounds; Hip Joint; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Osteoarthritis, Hip; Reproducibility of Results; Sensitivity and Specificity

2013